InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（4 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
4
T+90 胜率
100%
T+90 平均收益
+16.2%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the detailed record of transactions filed by Holstein Jens, 董事. Director active across 1 company, notably Veracyte, INC.. Aggregated, 9 disclosures have been published. Breakdown: 1 buy · 4 sells. Total volume traded: €366k. Activity tracked since 3 June 2021. The latest transaction was filed on 20 November 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Holstein Jens
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
1,491 股@ US$40.952614.5% 占其流量Common StockSEC:0001819880-25-000005:0
9,321 股0Common StockSEC:0001384101-25-000098:0
2,500 股@ US$28.0017.3% 占其流量Common StockSEC:0001384101-24-000122:0
2,500 股@ US$24.0014.8% 占其流量Common StockSEC:0001384101-24-000109:0
11,473 股0Common StockSEC:0001384101-24-000103:0
9,674 股0Common StockSEC:0001384101-23-000123:0
8,720 股@ US$16.26680.0044% mcap53.9% 占其流量Common StockSEC:0001384101-22-000088:0
8,720 股0Common StockSEC:0001384101-21-000112:0
2,000 股@ US$35.194615.9% 占其流量Common StockSEC:0001384101-21-000098:0
标准退出：2021年9月1日 (T+90)
9 条申报中的 9 条
About Holstein Jens
Jens Holstein is a Director at Veracyte, Inc. As a board member, he participates in the governance of the company and strategic decision-making. His experience in the biotechnology sector is valuable to Veracyte.
